Advanced research tools are shaping the Single-Cell Omics Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Single-Cell Omics Market Evolve From 2026 To 2030?

The single-cell omics market has seen rapid expansion in recent years. This market is projected to increase from $2.39 billion in 2025 to $2.78 billion in 2026, showing a compound annual growth rate (CAGR) of 16.3%. Historically, this growth can be attributed to several factors such as advancements in next-generation sequencing, an increase in academic research funding, a rise in cancer research initiatives, the demand for cellular heterogeneity analysis, and improvements in cell isolation technologies.

The single-cell omics market is projected to experience swift expansion in the coming years. By 2030, its size is anticipated to reach $5.27 billion, demonstrating a compound annual growth rate (CAGR) of 17.4%. This expansion throughout the forecast period can be attributed to factors such as the broadening of precision medicine initiatives, the incorporation of AI into omics analysis, a rise in pharmaceutical R&D spending, increased uptake in clinical diagnostics, and the creation of more affordable single-cell platforms. Key trends for the same period encompass the growing acceptance of multi-omics strategies, an increasing need for high-resolution cellular examination, the broadening of single-cell applications in oncology studies, enhanced utilization of microfluidics for isolating cells, and the standardization of workflows for single-cell analysis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

What Drivers Are Influencing The Single-Cell Omics Market?

The increasing incidence of cancer is anticipated to propel the expansion of the single-cell omics market moving forward. Cancer describes a collection of illnesses that can arise in virtually any organ or tissue within the body when abnormal cells multiply uncontrollably, bypass their usual boundaries, and either spread to other organs or infiltrate adjacent body parts. Single-cell omics data has been significantly employed in identifying biomarkers for cancer diagnosis, predicting prognosis, and discovering new therapeutic targets in specified clinical cohorts. For instance, in May 2024, according to the National Institutes of Health, a US-based government agency, approximately 18.1 million individuals in the United States were living as cancer survivors as of January 2022. This number is expected to rise to 22.5 million by 2032. Thus, the growing prevalence of cancer is a primary driver for the growth of the single-cell omics market.

Which Segment Areas Are Covered In The Single-Cell Omics Market Analysis?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

What Key Developments And Trends Are Impacting The Single-Cell Omics Market?

Key companies within the single-cell omics market are concentrating on developing advanced kits, including sequencing kits, to serve single-cell applications and increase their revenue in the sector. Sequencing kits represent pre-packaged sets of necessary reagents and materials created for genetic sequencing processes, thus streamlining laboratory workflows. For example, in February 2023, Singular Genomics Systems, Inc., a US-based firm leveraging novel next-generation sequencing (NGS), launched its Max Read Kits for single-cell sequencing, intended for use on the G4 Sequencing Platform. The Max Read Kits are designed to be compatible with widely used 10x Genomics assays and provide the flexibility to sequence 4 to 16 samples per run. These kits offer 800 million reads per flow cell with an impressive 80% to 90% Q30 quality. Singular Genomics is also improving the quality specifications of the G4 Sequencing Platform’s F2 and F3 flow cells, achieving up to 1.8 billion reads per run on the F3 flow cells for certain applications.

Which Global Companies Are Actively Competing In The Single-Cell Omics Market?

Major companies operating in the single-cell omics market are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Sartorius AG, Illumina Inc, Bio Rad Laboratories Inc, Qiagen NV, Tecan Group Ltd, BGI Genomics Co Ltd, 10x Genomics Inc, Takara Bio Inc, NanoString Technologies Inc, Vizgen, Deepcell, Mission Bio Inc, Standard BioTools Inc, CYTENA GmbH, Single Cell Discoveries

Read the full single-cell omics market report here:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Single-Cell Omics Market?

North America was the largest region in the single-cell omics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Single-Cell Omics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

Browse Through More Reports Similar to the Global Single-Cell Omics Market 2026, By The Business Research Company

Single Cell Omics Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Single Cell Analysis Market 2026

https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market

Single Cell Genome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795